Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 16/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.52 |
| ▸ | KDM1A | O60341 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | RARB | P10826 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19683023 | 0.89 | HDAC1 (0.49) | HDAC1HDAC2KDM1AMAOARARB | |
| SCHEMBL17483929 | 0.89 | HDAC1 (0.50) | HDAC1HDAC2KDM1AMAOARARB | |
| SCHEMBL17483935 | 0.87 | HDAC3 (0.49) | HDAC1HDAC2KDM1AMAOAHDAC3 | |
| SCHEMBL17483931 | 0.87 | HDAC1 (0.49) | HDAC1HDAC2KDM1AMAOAHDAC3 | |
| SCHEMBL19683024 | 0.87 | HDAC1 (0.52) | HDAC1HDAC2KDM1AMAOARARB | |
| SCHEMBL17483934 | 0.84 | HDAC6 (0.65) | HDAC1HDAC2KDM1AMAOAHDAC3 | |
| SCHEMBL17483969 | 0.84 | HDAC1 (0.44) | HDAC1HDAC2KDM1AMAOARARB | |
| SCHEMBL17483930 | 0.83 | HDAC1 (0.54) | HDAC1HDAC2HDAC3 | |
| SCHEMBL17478501 | 0.83 | HDAC1 (0.71) | HDAC1HDAC2KDM1AMAOARARB | |
| SCHEMBL17478531 | 0.83 | HDAC1 (0.71) | HDAC1HDAC2KDM1AMAOARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170349540-A1 | HISTONE DEACETYLASE INHIBITORS | THE GENERAL HOSPITAL CORPORATION | 2017-12-07 | — | — | US | disclosed |
| WO-2016018795-A1 | HISTONE DEACETYLASE INHIBITORS | THE GENERAL HOSPITAL CORPORATION (US) | 2016-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349540-A1 | HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC11, HDAC5 | HDAC1 1/4885HDAC2 4/4885KDM1A 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.